Product Information
FT ALLERGY (FEXO) 180 MG TAB is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.2302 per EA under NDC 70677123901. Its NADAC has been published 117 times since Jul 10, 2024.
FDA first approved this application on Aug 13, 2018.
Strength
180 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677123901
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FEXOFENADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210137FDA Approved
8/13/2018
On Market Since
2/22/2024
Pharmacological Classes
Price Statistics
The NADAC for FT ALLERGY (FEXO) 180 MG TAB has been published 117 times since Jul 10, 2024, and over the history we have for it it has declined 16.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2302 per EA |
|---|---|
| All-time high | $0.2839 (Sep 11, 2024) |
| All-time low | $0.2079 (Nov 20, 2024) |
| 52-week high | $0.2728 |
| 52-week low | $0.2302 |
| Median price | $0.2565 |
| Average price | $0.2540 |
| Largest weekly change | -24.0% (Nov 20, 2024) |
| Weeks tracked | 117 |
| Tracking since | Jul 10, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the FEXOFENADINE HCl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
FEXOFENADINE HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT ALLERGY (FEXO) 180 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for FT ALLERGY (FEXO) 180 MG TAB, manufactured by Strategic Sourcing Services LLC, is $0.2302 per EA (NDC 70677123901), effective Sep 30, 2026.
How has the price of FT ALLERGY (FEXO) 180 MG TAB changed over time?
Over the history we have for it, the NADAC for FT ALLERGY (FEXO) 180 MG TAB has declined 16.3%. It has been tracked across 117 weekly CMS publications since Jul 10, 2024.
What are the highest and lowest recorded NADAC prices for FT ALLERGY (FEXO) 180 MG TAB?
Since Jul 10, 2024, the NADAC for FT ALLERGY (FEXO) 180 MG TAB has ranged from a low of $0.2079 (Nov 20, 2024) to a high of $0.2839 (Sep 11, 2024), with a median of $0.2565 per EA.
Are there cheaper alternatives to FT ALLERGY (FEXO) 180 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of FT ALLERGY (FEXO) 180 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FT ALLERGY (FEXO) 180 MG TAB?
FT ALLERGY (FEXO) 180 MG TAB (NDC 70677123901) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.